TRIVARX LTD (TRI)
AI Coverage Rating: Low
ASX AI Signals has generated 0 signals for TRI during the last 90 days, indicating low trading activity
TRI Share Price | |
| Current Price | $0.023 |
| 52 Week High | $0.031 |
| 52 Week Low: | $0.007 |
| Trading at (% of 52 Week High) | 74.19% |
Business Overview
Trivarx Ltd (ASX: TRI) is an Australian biotechnology company focused on developing innovative immuno-oncology therapies. The company is advancing treatments designed to harness the body's immune system to target and destroy cancer cells.
ASX Sector Overview
Sector: Health Care Equipment & Services
The Health Care Equipment & Services sector on the ASX includes companies that produce medical devices, equipment, and supplies, as well as those providing healthcare-related services. This sector covers a wide range of products such as surgical instruments, diagnostic machines, and health monitoring devices. It also includes businesses involved in healthcare management, medical laboratories, and support services. These companies play a key role in supporting hospitals, clinics, and other healthcare providers to improve patient care. The sector is influenced by factors like technological advances, regulatory changes, and demand for healthcare services.
Latest AI Recommendation
Latest TRIVARX LTD(TRI) News
Unlock All ASX AI Signals
Get access to daily BUY & SELL signals, advanced AI analysis, watchlists and email alerts.
14 Day Free Trial • Cancel Anytime • Founders Price $15/month
Start My Free Trial